Minimal residual disease: the advantages of digital over analog polymerase chain reaction

被引：5

作者：

Ross, David M. ^{[1
,2
,3
]}

Branford, Susan ^{[3
,4
]}

机构：

[1] SA Pathol, Haematol, Adelaide, SA, Australia

[2] Flinders Univ & Med Ctr, Adelaide, SA, Australia

[3] Univ Adelaide, Adelaide, SA, Australia

[4] SA Pathol, Genet & Mol Pathol, Adelaide, SA, Australia

来源：

LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 07期

关键词：

CHRONIC MYELOID-LEUKEMIA; COMPLETE MOLECULAR REMISSION; QUANTITATIVE PCR; IMATINIB; DNA;

D O I：

10.3109/10428194.2011.580481

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1161 / 1163

页数：3

共 10 条

[1] Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA [J].

Bartley, P. A. ;

Ross, D. M. ;

Latham, S. ;

Martin-Harris, M. H. ;

Budgen, B. ;

Wilczek, V. ;

Branford, S. ;

Hughes, T. P. ;

Morley, A. A. .

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (06) :E222-E228

[2] The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease [J].

Bose, S ;

Deininger, M ;

Gora-Tybor, J ;

Goldman, JM ;

Melo, JV .

BLOOD, 1998, 92 (09) :3362-3367

[3] Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay [J].

Goh, Hyun-Gyung ;

Lin, Min ;

Fukushima, Takashi ;

Saglio, Giuseppe ;

Kim, Dongho ;

Choi, Soo-Young ;

Kim, Soo-Hyun ;

Lee, Jeong ;

Lee, Young-Seok ;

Oh, Sang-Mi ;

Kim, Dong-Wook .

LEUKEMIA & LYMPHOMA, 2011, 52 (05) :896-904

[4] Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial [J].

Mahon, Francois-Xavier ;

Rea, Delphine ;

Guilhot, Joelle ;

Guilhot, Francois ;

Huguet, Francoise ;

Nicolini, Franck ;

Legros, Laurence ;

Charbonnier, Aude ;

Guerci, Agnes ;

Varet, Bruno ;

Etienne, Gabriel ;

Reiffers, Josy ;

Rousselot, Philippe .

LANCET ONCOLOGY, 2010, 11 (11) :1029-1035

[5] Molecular Monitoring of Residual Disease in Chronic Myeloid Leukemia by Genomic DNA Compared with Conventional mRNA Analysis [J].

Mattarucchi, Elia ;

Spinelli, Orietta ;

Rambaldi, Alessandro ;

Pasquali, Francesco ;

Lo Curto, Francesco ;

Campiotti, Leonardo ;

Porta, Giovanni .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (05) :482-487

[6] Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR [J].

Oehler, V. G. ;

Qin, J. ;

Ramakrishnan, R. ;

Facer, G. ;

Ananthnarayan, S. ;

Cummings, C. ;

Deininger, M. ;

Shah, N. ;

McCormick, F. ;

Willis, S. ;

Daridon, A. ;

Unger, M. ;

Radich, J. P. .

LEUKEMIA, 2009, 23 (02) :396-399

[7]

Rawer D, 2003, LEUKEMIA, V17, P2527, DOI 10.1038/sj.leu.2403191

[8]

Rawer D, 2003, LEUKEMIA, V17, P2528

[9] Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR [J].

Ross, D. M. ;

Branford, S. ;

Seymour, J. F. ;

Schwarer, A. P. ;

Arthur, C. ;

Bartley, P. A. ;

Slader, C. ;

Field, C. ;

Dang, P. ;

Filshie, R. J. ;

Mills, A. K. ;

Grigg, A. P. ;

Melo, J. V. ;

Hughes, T. P. .

LEUKEMIA, 2010, 24 (10) :1719-1724

[10] In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib [J].

Sobrinho-Simoes, Manuel ;

Wilczek, Vicki ;

Score, Joannah ;

Cross, Nicholas C. P. ;

Apperley, Jane F. ;

Melo, Junia V. .

BLOOD, 2010, 116 (08) :1329-1335

← 1 →